Celdach 50mg Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Oxaliplatin (50mg)
Overview Celdach 50mg Injection
Oncaspar 50mg Injection treats colorectal cancer by inhibiting or retarding cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined individually by your physician based on your condition and may fluctuate. Strict adherence to your doctor's prescription is crucial; incorrect usage or overdose can lead to severe adverse reactions. While therapeutic effects might not be immediately apparent (taking several weeks or months), discontinue use only under medical supervision. Common side effects include nausea, tiredness, vomiting, and diarrhea. This medication can lower blood cell counts (red and white), increasing infection risk. Serious allergic reactions (e.g., mouth sores, rash, itching, breathing difficulties) necessitate immediate medical attention. Regular blood tests monitoring blood cell levels, along with heart, liver, and uric acid levels, are essential. Prior to commencement, inform your doctor of any pre-existing heart, liver, or kidney conditions, and all medications, especially those for infections, as interactions are possible. Use during pregnancy or breastfeeding is contraindicated. Male infertility is a potential side effect; sperm preservation should be discussed with your doctor beforehand. Due to potential dizziness, driving is discouraged after administration.
Uses of Celdach 50mg Injection
Colorectal cancer
Major Benefits of Celdach 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Celdach 50mg Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Celdach 50mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Celdach 50mg Injection works:
Oncaspar 50mg injection is a medication used in cancer treatment. Its mechanism involves disrupting the genetic structure (DNA and RNA) of cancerous cells, thereby halting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining alcohol with a 50mg Celdach injection is undetermined. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Administering Celdach 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional circumstances involving life-threatening conditions, a physician might consider prescribing it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Celdach 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
The administration of Celdach 50mg Injection, or Oxaliplatin treatment, can induce side effects such as dizziness, nausea, vomiting, and other neurological symptoms impacting gait. These effects may impair driving ability.
KidneyCAUTION
Exercise caution when administering Celdach 50mg Injection to individuals with severe kidney impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Celdach 50mg Injection use in such patients is limited. Dosage alteration is not advised for those with mild or moderate kidney dysfunction.
LiverCAUTION
For individuals with hepatic impairment, administration of Celdach 50mg Injection requires careful monitoring. Dosage modification of Celdach 50mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Celdach 50mg Injection :
Forgetting a Celdach 50mg Injection? Seek medical advice immediately.
Facts to Know About Celdach 50mg Injection
| Label | Value |
|---|---|
| Chemical Category | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action class | Platinum-based Anticancer Agents |
3,018 People bought this recently